LADENBURG THALMANN FINANCIAL SERVICES INC. - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 15 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$25,000
+316.7%
10,394
+146.1%
0.00%
Q3 2019$6,000
+500.0%
4,223
+1240.6%
0.00%
Q2 2019$1,000
-75.0%
315
-75.4%
0.00%
Q1 2019$4,000
-20.0%
1,281
+59.7%
0.00%
Q4 2018$5,0008020.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Virtu Financial LLC 77,694$27,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 36,461$12,0000.00%
ROYAL BANK OF CANADA 25$00.00%
VANGUARD GROUP INC 616,855$216,0000.00%
Private Advisor Group, LLC 21,400$7,0000.00%
UBS Group AG 35,517$12,0000.00%
TWO SIGMA INVESTMENTS, LP 58,389$20,0000.00%
OSAIC HOLDINGS, INC. 8,321$3,0000.00%
FMR LLC 7$00.00%
WELLS FARGO & COMPANY/MN 1,005$00.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders